drugset / Trial / NCT01262092

Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals

NCT01262092 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This study involves inducting treatment seeking opioid dependent participants onto buprenorphine. Once the participant reaches a stable dose they will receive either placebo or gabapentin to determine if gabapentin helps ease withdrawal symptoms while the participant undergoes a 10-day buprenorphine detoxification.

Timeline

Start
2010-10
Primary completion
2011-12
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Unknown 1600 mg —
Comparator Buprenorphine Other / unclassified 12 mg —